Pharmacovigilance &Drug Safety

July 27-28, 2020Zurich, Switzerland

13th International Conference and Exhibition on

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAMDAY 1

Monday, 27th July

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Pre-Clinical and Clinical Trials

Talks On: Drug Safety

Pre-Clinical Testing Drug Safety Updates

Scientific Models for Pre-Clinical and Clinical Trials Drug Safety Solutions

Designing of trials: pre-clinical studies Drug Safety Training

Bioassay and its types Drug Safety Surveilance

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK

MEETING HALL 01 MEETING HALL 02

14:00-16:00Talks On: Adverse Drug Reactions

Talks On: Pharmacovigilance and Risk Manage-ment

Acute and chronic adverse drug events Information technology in pharmacovigilance and promoting companies

Classification of various adverse drug reactions

Review of softwares used in pharmacovigilance and clinical trials

Mechanism of adverse drug reactions Implementation of Risk Minimization Plans

Assessing and reporting adverse drug reactions

Risk communication: Interface between pharmacovigilance, sales and marketing

Expected and un-expected drug reactions and its reporting

Post marketing reports on adverse effects

16:00-16:20 COFFEE BREAK

MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Pharmacovigi-lance & Drug Safety

Workshop

Visit: https://pharmacovigilance.pharmaceuticalconferences.comSubmit Abstract

SCIENTIFIC PROGRAMDAY 2

Tuesday, 28th July

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES

10:30-10:50 COFFEE BREAK

MEETING HALL 01 MEETING HALL 02

10:50-12:50 Talks On: Good Pharmacovigilance Practice

Talks On: Pharmacy Practices and its Challenges

Role of pharmacovigilance and pharmacoepidemiology in risk management Pharmacy practice and its guidelines

Good reporting practices Challenges in compounding and dispensing practice

Interpreting safety signals Dosage regimen, drug toxicity and drug safety measures

Randomized clinical trials Pharmacoepidemiology of drug shortages

Ethical and social aspects of drug use Drug Labelling

12:50-13:35 LUNCH BREAK

MEETING HALL 01 MEETING HALL 02

13:35-15:55 Talks On: Clinical Trials on Various Disorders

Talks On: Data Quality Management and Analysis

Emerging technology in clinical trials Genomics for pharma R&D

Recent clinical trials on AIDS Cancer immunotherapy

Clinical trials on benign and malignant tumors

Preclinical and translational immuno-oncology

Clinical trials on cardiovascular diseases Immuno-oncology biomarkers and companion

Clinical trials on diabetes Immunology and drug discovery

Clinical trials of monoclonal and polyclonal antibodies

NGS assay selection, validation and compliance

Clinical trials on drugs used in psychological disorders Coverage advanced diagnostics

15:55-16:15 COFFEE BREAK

MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop

Awards & Closing Ceremony

Visit: https://pharmacovigilance.pharmaceuticalconferences.com/Submit Abstract

Essam Ghanem Celyad Biopharmaceutical, Belgium

Maria Amparo Lopez Ruiz Cardenal Herrera University, Spain

Aaron Damien Barzey ADB Medical, UK

Cristina Scavone University of Campania LuiVanvitelli, Italy

Raymond R Mattingly Wayne State University School of Medicine, USA

Nathan Cummins Mayo Clinic, USA

Cristina Damatarca Agility Clinical, USA

Gamal Hussein South College School of Pharmacy, USA

Eleni Konstantinou Harvard Medical School, USA

Silvia Leone University of Genoa, Italy

Silvia Cacho-Elizondo IPADE Business School, USA

Tomaz Crochemore Israelita Albert Einstein Hospital, Brazil

Kety Mirkovic Kos PharmaKos d.o.o., Croatia

Mervat Alsous Applied Science Private University, Jordan

Jyoti B Sharma Tata Memorial Centre, India

Tomasz Ząbkowski Military Medical Institute, Poland

Alexey Skripkin BIOCAD, Russian Federation, Russia

Anika Staack, EU-QPPV, Germany

Meital Simhi Ben Gurion University of the Negev, Israel

Subodh Bhardwaj New York & Inventprise, USA

Eliana Silva de Moraes Food and Drug Law, Brazil

Safa Alizadeh University of Medical Sciences, Iran

Saed Amarneh Laniado Hospital Sanz Medical Centre, Israel

Fiorenza Stagni University of Bologna, Italy

PAST AFFILIATESPA

ST A

FFIL

IATE

S

Visit: https://pharmacovigilance.pharmaceuticalconferences.com/Submit Abstract

Anna Helena Stahl Otsuka Novel Products GmbH, Germany

Parminder Kaur RegPak BioPharma Consulting, Netherlands

Alistair Coates Oviya MedSafe, UK

G Robert Jones Cancer Research Unit, UK

Pramod Wable Daiichi Sankyo Development Ltd, UK

Hosu Anamaria Delia University Babes-Bolya, Romania

Pascal Klaus Universitäts medizin Berlin, Germany

Giovanni Furlan Helsinn Birex Pharmaceuticals, Ireland

M Ángeles Piñero-López University of Barcelona, Spain

Mohamed M El-Khawanki Najran University, Saudi Arabia

PAST AFFILIATESPA

ST A

FFIL

IATE

S

Visit: https://pharmacovigilance.pharmaceuticalconferences.com/Submit Abstract

Zurich Attractions

Chin

ese

Garde

n

Bellerive Museum

Botan

ical G

arde

n of

the

Unive

rsity

of Z

urich

Limm

atqu

ai

Lake

Zur

ich a

nd

Burkl

ipla

tz

Swiss

Nat

iona

l

Mus

eum

St. P

eter

Zur

ich

Frau

mun

ster

Gross

mun

ster

Pharmacovigilance Reminisce

Visit: https://pharmacovigilance.pharmaceuticalconferences.com/Submit Abstract